30jili U.S. Senator Ron Wyden of Oregon announced a new bill to secure the networks of American telecommunications companies breached by Salt Typhoon Chinese state hackers earlier this year. Wyden's " Secure American Communications Act " will order the Federal Communications Commission (FCC) to issue binding cybersecurity rules and implement the security requirements demanded since 1994 by legislation that instructs telecom providers to secure their phone and wireless networks from breaches. Telecom carriers will have to test their systems annually for security vulnerabilities, patch them, and document their findings and "all corrective measures." They'll also have to contract independent auditors for annual compliance audits with FCC cybersecurity rules and document any noncompliance findings. "It was inevitable that foreign hackers would burrow deep into the American communications system the moment the FCC decided to let phone companies write their own cybersecurity rules. Telecom companies and federal regulators were asleep on the job and as a result, Americans' calls, messages, and phone records have been accessed by foreign spies intent on undermining our national security," Wyden said today . "Congress needs to step up and pass mandatory security rules to finally secure our telecom system against an infestation of hackers and spies." On Thursday, FCC Chairwoman Jessica Rosenworcel announced that the agency would also act "urgently" to ensure that American telecom carriers are required to secure their networks. The Salt Typhoon telecom breaches CISA and the FBI confirmed the hacks in late October following reports that Chinese threat actors had hacked multiple telcos , including T-Mobile, AT&T, Verizon, and Lumen Technologies. Even though the timing of these breaches is still unclear, the Chinese hackers had access for "months or longer." This reportedly allowed them to steal substantial internet traffic from carriers providing services to American businesses and millions of customers. Last week, President Biden's deputy national security adviser Anne Neuberger told reporters during a Wednesday press briefing that the Salt Typhoon hacking group breached eight U.S. telecoms and carriers in dozens of other countries. The White House official said that "at this time, we don't believe any classified communications have been compromised," while a senior CISA official added in a Tuesday press call that they couldn't "say with certainty that the adversary has been evicted." CISA and FBI officials also advised Americans to use encrypted messaging apps to minimize the risk of communications interception by Chinese hackers and released guidance to help telecom infrastructure system admins and engineers harden systems against Salt Typhoon attacks. Also tracked as Earth Estries, Ghost Emperor, FamousSparrow, and UNC2286, the Salt Typhoon Chinese state-sponsored hacking group has been active since at least 2019, breaching government entities and telecom companies across Southeast Asia.Profit-taking pulls KSE-100 index down by 1,509 points

Barclays PLC lifted its position in Fate Therapeutics, Inc. ( NASDAQ:FATE – Free Report ) by 245.3% during the 3rd quarter, HoldingsChannel reports. The firm owned 424,277 shares of the biopharmaceutical company’s stock after buying an additional 301,389 shares during the period. Barclays PLC’s holdings in Fate Therapeutics were worth $1,485,000 at the end of the most recent reporting period. A number of other institutional investors and hedge funds also recently made changes to their positions in FATE. Deerfield Management Company L.P. Series C grew its position in Fate Therapeutics by 62.3% during the second quarter. Deerfield Management Company L.P. Series C now owns 3,555,871 shares of the biopharmaceutical company’s stock worth $11,663,000 after buying an additional 1,365,463 shares in the last quarter. Dimensional Fund Advisors LP grew its holdings in shares of Fate Therapeutics by 100.4% during the second quarter. Dimensional Fund Advisors LP now owns 2,130,280 shares of the biopharmaceutical company’s stock worth $6,987,000 after purchasing an additional 1,067,101 shares in the last quarter. Acadian Asset Management LLC increased its position in shares of Fate Therapeutics by 17.2% in the second quarter. Acadian Asset Management LLC now owns 2,008,862 shares of the biopharmaceutical company’s stock worth $6,587,000 after purchasing an additional 294,738 shares during the last quarter. Federated Hermes Inc. raised its stake in Fate Therapeutics by 2.4% in the second quarter. Federated Hermes Inc. now owns 1,031,505 shares of the biopharmaceutical company’s stock valued at $3,383,000 after purchasing an additional 24,127 shares in the last quarter. Finally, Integral Health Asset Management LLC lifted its position in Fate Therapeutics by 325.0% during the second quarter. Integral Health Asset Management LLC now owns 850,000 shares of the biopharmaceutical company’s stock valued at $2,788,000 after purchasing an additional 650,000 shares during the last quarter. Hedge funds and other institutional investors own 97.54% of the company’s stock. Insider Activity In other news, Director Redmile Group, Llc acquired 397,964 shares of the stock in a transaction dated Friday, December 20th. The stock was purchased at an average cost of $1.68 per share, with a total value of $668,579.52. Following the completion of the purchase, the director now owns 12,884,277 shares in the company, valued at approximately $21,645,585.36. The trade was a 3.19 % increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink . Insiders own 5.00% of the company’s stock. Wall Street Analysts Forecast Growth Read Our Latest Stock Report on Fate Therapeutics Fate Therapeutics Stock Down 0.6 % NASDAQ FATE opened at $1.61 on Friday. The company has a 50-day simple moving average of $2.38 and a two-hundred day simple moving average of $3.26. Fate Therapeutics, Inc. has a 12-month low of $1.56 and a 12-month high of $8.83. The firm has a market cap of $183.37 million, a price-to-earnings ratio of -0.98 and a beta of 1.95. Fate Therapeutics ( NASDAQ:FATE – Get Free Report ) last released its earnings results on Tuesday, November 12th. The biopharmaceutical company reported ($0.40) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.42) by $0.02. Fate Therapeutics had a negative return on equity of 45.88% and a negative net margin of 1,325.43%. The company had revenue of $3.07 million during the quarter, compared to analyst estimates of $0.88 million. Equities analysts expect that Fate Therapeutics, Inc. will post -1.72 earnings per share for the current fiscal year. About Fate Therapeutics ( Free Report ) Fate Therapeutics, Inc, a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. The company's chimeric antigen receptor (CAR)-targeted NK and T-cell product candidates include FT576 to treat multiple myeloma, and FT522, to treat lymphoma and autoimmune disorders. Recommended Stories Want to see what other hedge funds are holding FATE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Fate Therapeutics, Inc. ( NASDAQ:FATE – Free Report ). Receive News & Ratings for Fate Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fate Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter .Hercules Capital: Are The Dividends Safe? I'm Buying!

Iran envoy pays tribute to Quaid-e-Azam

Trump promises fast-track permitting for companies that invest $1 billion in USBlackCEO Launches Groundbreaking 'Extreme Business Makeover' Program to Transform Black-Owned Businesses into Industry GiantsTrump’s DHS pick Kristi Noem expected to ‘sail through’ confirmation

Knicks News: Matt Ryan Agrees to 2-Way Contract; Boo Buie Waived

2024: A Great Year for Audiophiles, But 2025 is Shaping Up to be Even Better!

Middle East latest: Israeli raid and airstrikes in West Bank kill at least 8 Palestinians

A lot has changed since Natalie Bassingthwaighte's star first rose in the early-to-mid-2000s, but she is . or signup to continue reading Natalie will star in Shirley Valentine, a one-woman play about a housewife stuck in a world of routine who finds herself during a trip to Greece. Affectionately known as Nat Bass, the 49-year-old singer and has never led a life of routine but said Shirley's journey still resonated deeply with her. "It just has this kind of essence of creating your own destiny and making decisions for and finding yourself again after having children, your children leaving home, being married. "I think we all have that. It is not just women; men and women ... Trying to come back to self, I guess ... but also a new discovery as well." Natalie's journey to self-discovery is a poignant one. She has spoken openly about her struggles with mental health over the years. She separated from her husband and Rogue Traders bandmate Cameron McGlinchey in August 2023. In November of the same year, she went public about her relationship with her new partner, Pip Loth. The announcement of her union with Loth, who is non-binary, sparked an angry backlash from social media trolls. "It was so difficult because I feel like no one should have the right to be able to comment on anyone's joy in a negative way," she said. "It's hard enough to be in this industry, to have children and a family and to, you know, be in this space, but to have to then sort of announce it publicly and then defend yourself, it's not fun." Despite the challenges of dealing with the ugly backlash, Natalie says she is in a great space. Her family life is good; she and McGlinchey remain on excellent terms, and for every negative comment, there were many more positive ones. At almost 50, Natalie still looks great. So, how does she keep herself in shape mentally and physically amidst a hectic work schedule? She exercises as much as possible and particularly enjoys pilates and walking. She eats well, takes vitamins, tries to ensure she is getting sleep, and is a big reader, especially of biographies. She also meditates for 10 minutes each morning and 10 minutes every night. "A lot of people get scared of meditation ... a few years ago, I couldn't think of anything worse. I didn't even know how to do it ... I persevered with it." "You just have to not think that it's meditation and that you're just listening to someone's voice telling you a story. Quite quickly, you can get very grounded and very good at being able to switch off whenever you need it, wherever you are." While she has maintained a breakneck pace over the years, she said she would like to strike a balance over the next 10 years, continuing to find great work opportunities and spending more time at home. Natalie is excited about starring in Shirley Valentine. While she has performed extensively on stage, this will be her first one-woman show, and she is looking forward to the challenge of captivating an audience single-handedly. She is also a huge fan of Willy Russell's script. "I think the thing that I loved about it [most was], it was so funny. The writing is beautiful. It's life-affirming. It's heartwarming." Hi, my name is Rowan Cowley and I'm a reporter for The Senior newspaper. I have special interests in the areas of entertainment, the arts and history and would like to hear from anyone who feels they have a good story idea. Hi, my name is Rowan Cowley and I'm a reporter for The Senior newspaper. I have special interests in the areas of entertainment, the arts and history and would like to hear from anyone who feels they have a good story idea. DAILY Today's top stories curated by our news team. WEEKDAYS Grab a quick bite of today's latest news from around the region and the nation. WEEKLY The latest news, results & expert analysis. WEEKDAYS Catch up on the news of the day and unwind with great reading for your evening. WEEKLY Get the editor's insights: what's happening & why it matters. WEEKLY Love footy? We've got all the action covered. WEEKLY Every Saturday and Tuesday, explore destinations deals, tips & travel writing to transport you around the globe. WEEKLY Going out or staying in? Find out what's on. WEEKDAYS Sharp. Close to the ground. Digging deep. Your weekday morning newsletter on national affairs, politics and more. TWICE WEEKLY Your essential national news digest: all the big issues on Wednesday and great reading every Saturday. WEEKLY Get news, reviews and expert insights every Thursday from CarExpert, ACM's exclusive motoring partner. TWICE WEEKLY Get real, Australia! Let the ACM network's editors and journalists bring you news and views from all over. AS IT HAPPENS Be the first to know when news breaks. DAILY Your digital replica of Today's Paper. Ready to read from 5am! DAILY Test your skills with interactive crosswords, sudoku & trivia. Fresh daily! Advertisement AdvertisementTyler Perry Studios president dies in Florida plane crash: Deputies